J.M. Thomas

1.4k total citations
31 papers, 915 citations indexed

About

J.M. Thomas is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Rheumatology. According to data from OpenAlex, J.M. Thomas has authored 31 papers receiving a total of 915 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 18 papers in Oncology and 9 papers in Rheumatology. Recurrent topics in J.M. Thomas's work include Sarcoma Diagnosis and Treatment (18 papers), Vascular Tumors and Angiosarcomas (7 papers) and Immunotherapy and Immune Responses (5 papers). J.M. Thomas is often cited by papers focused on Sarcoma Diagnosis and Treatment (18 papers), Vascular Tumors and Angiosarcomas (7 papers) and Immunotherapy and Immune Responses (5 papers). J.M. Thomas collaborates with scholars based in United Kingdom, United States and France. J.M. Thomas's co-authors include Kasim A. Behranwala, Andrew Hayes, Omar Al‐Muderis, Roger A Hern, Matthew A. Clark, Cyril Fisher, Sherianne Fish, C. Fisher, T. Davidson and Martin Gore and has published in prestigious journals such as British Journal of Cancer, British journal of surgery and European Journal of Cancer.

In The Last Decade

J.M. Thomas

30 papers receiving 868 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
J.M. Thomas United Kingdom	19	539	529	181	168	121	31	915
Katsushige Yamashiro Japan	22	423 0.8×	606 1.1×	182 1.0×	242 1.4×	126 1.0×	78	1.4k
Onofre Sanmartín Spain	20	640 1.2×	479 0.9×	179 1.0×	202 1.2×	85 0.7×	87	1.4k
R. S. Benjamin United States	12	393 0.7×	665 1.3×	104 0.6×	334 2.0×	154 1.3×	23	1.1k
Hs Koops Netherlands	14	284 0.5×	312 0.6×	219 1.2×	94 0.6×	63 0.5×	24	737
Adam Dangoor United Kingdom	11	284 0.5×	435 0.8×	117 0.6×	117 0.7×	102 0.8×	23	667
A Niezabitowski Poland	14	277 0.5×	382 0.7×	109 0.6×	155 0.9×	80 0.7×	52	689
Carlos Guillén Spain	18	563 1.0×	281 0.5×	110 0.6×	101 0.6×	56 0.5×	66	999
Cher‐Wei Liang Taiwan	18	262 0.5×	429 0.8×	116 0.6×	247 1.5×	41 0.3×	53	975
Thomas Weisenburger United States	12	312 0.6×	679 1.3×	249 1.4×	203 1.2×	93 0.8×	26	854
H. Stephens Moseley United States	15	447 0.8×	268 0.5×	173 1.0×	221 1.3×	30 0.2×	35	940

Countries citing papers authored by J.M. Thomas

Since Specialization

Citations

This map shows the geographic impact of J.M. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.M. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.M. Thomas more than expected).

Fields of papers citing papers by J.M. Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.M. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.M. Thomas. The network helps show where J.M. Thomas may publish in the future.

Co-authorship network of co-authors of J.M. Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of J.M. Thomas. A scholar is included among the top collaborators of J.M. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.M. Thomas. J.M. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Möhn, Nora, Thomas Skripuletz, S. Carl, et al.. (2025). Complement activation profiles in patients with immune checkpoint inhibitor-associated neuromuscular immune-related adverse events. Journal of Neurology. 272(7). 459–459.

Thomas, J.M., et al.. (2011). Treatment for breast sarcoma: A large, single-centre series. European Journal of Surgical Oncology. 37(8). 703–708. 20 indexed citations

Hayes, Andrew, Susan J. Neuhaus, Matthew A. Clark, & J.M. Thomas. (2006). Isolated Limb Perfusion With Melphalan and Tumor Necrosis Factor α for Advanced Melanoma and Soft-Tissue Sarcoma. Annals of Surgical Oncology. 14(1). 230–238. 54 indexed citations

Behranwala, Kasim A., Roger A Hern, Omar Al‐Muderis, & J.M. Thomas. (2004). Prognosis of Lymph Node Metastasis in Soft Tissue Sarcoma. Annals of Surgical Oncology. 11(7). 714–719. 116 indexed citations

Hayes, Andrew, et al.. (2004). Serum vascular endothelial growth factor as a tumour marker in soft tissue sarcoma. British journal of surgery. 91(2). 242–247. 48 indexed citations

Behranwala, Kasim A., et al.. (2004). Intra‐abdominal metastases from soft tissue sarcoma. Journal of Surgical Oncology. 87(3). 116–120. 21 indexed citations

Behranwala, Kasim A., et al.. (2004). Vulvar soft tissue tumors. International Journal of Gynecological Cancer. 14(1). 94–99. 24 indexed citations

Clark, Matthew A. & J.M. Thomas. (2003). Portsite Recurrence After Laparoscopy for Staging of Retroperitoneal Sarcoma. Surgical Laparoscopy Endoscopy & Percutaneous Techniques. 13(4). 290–291. 19 indexed citations

Hughes, Michael & J.M. Thomas. (2000). Sarcoma metastases due to iatrogenic implantation. European Journal of Surgical Oncology. 26(1). 50–52. 28 indexed citations

10.

Palmer, Kay, J. Moore, Robert C. Rees, et al.. (1999). Gene Therapy with Autologous, Interleukin 2-Secreting Tumor Cells in Patients with Malignant Melanoma. Human Gene Therapy. 10(8). 1261–1268. 66 indexed citations

11.

Chandran, Ravi, et al.. (1997). Extremity soft tissue sarcomas. European Journal of Cancer. 33. S115–S116. 1 indexed citations

12.

Savage, Philip, et al.. (1997). The natural history and management of Merkel cell carcinoma of the skin: A review of 22 patients treated at the Royal Marsden Hospital. Clinical Oncology. 9(3). 164–167. 40 indexed citations

13.

Patel, Poulam M., Claudia L. Flemming, Cyril Fisher, et al.. (1994). Generation of Interleukin-2-Secreting Melanoma Cell Populations from Resected Metastatic Tumors. Human Gene Therapy. 5(5). 577–584. 21 indexed citations

14.

Serpell, Jonathan W., et al.. (1991). Primary soft tissue tumours of the pelvis causing referred pain in the leg. Journal of Surgical Oncology. 47(1). 17–20. 9 indexed citations

15.

Robinson, Martin, Rosalind A. Eeles, I Fryatt, et al.. (1991). Limb function following conservation treatment of adult soft tissue sarcoma. European Journal of Cancer and Clinical Oncology. 27(12). 1567–1574. 66 indexed citations

16.

Serpell, Jonathan W., A B S Ball, Martin Robinson, et al.. (1991). Factors influencing local recurrence and survival in patients with soft tissue sarcoma of the upper limb. British journal of surgery. 78(11). 1368–1372. 22 indexed citations

17.

Hanson, P.J.V., J.M. Thomas, & J.V. Collins. (1987). Mycobacterium chelonei and abscess formation in soft tissues. Tubercle. 68(4). 297–299. 12 indexed citations

18.

Selby, Peter J., J.M. Thomas, Padraic Monaghan, J P Sloane, & Michael Peckham. (1980). Human tumour xenografts established and serially transplanted in mice immunologically deprived by thymectomy, cytosine arabinoside and whole-body irradiation. British Journal of Cancer. 41(1). 52–61. 40 indexed citations

19.

Thomas, J.M.. (1979). A lung colony clonogenic cell assay for human malignant melanoma in immune-suppressed mice and its use to determine chemosensitivity, radiosensitivity and the relationship between tumour size and response to therapy. British journal of surgery. 66(10). 696–700. 12 indexed citations

20.

Thomas, J.M., W H Redding, R. Charles Coombes, et al.. (1978). Failure to detect intra-abdominal metastases from breast cancer: a case for staging laparotomy. BMJ. 2(6131). 157–159. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact